Why I Can't Stop Buying Microsoft Stock

Microsoft’s Q2 FY2026 commercial remaining performance obligation surged to $625B, up 110% year-over-year, while Azure growth stayed near 40% and Q2 EPS beats continued. Net income rose 59.5% to $38.46B, operating cash flow increased 60.4% to $35.76B, and capital returned to shareholders reached $12.7B. Despite $29.88B in quarterly capex and a 12.9% YTD share-price decline, the article argues the stock remains attractively valued given strong AI-driven backlog and analyst support.

Analysis

The market is still underappreciating the difference between cyclical AI hype and a genuine annuity stream. A backlog this large only matters if conversion stays high, and the real tell is that Microsoft is funding capex from operating cash flow rather than balance-sheet strain; that keeps the AI buildout from becoming a capital overhang the way it has for weaker hyperscalers. The second-order winner is the enterprise software ecosystem around Azure, where workloads, security tools, data platforms, and developer tooling should see attach-rate expansion as customers standardize on a single AI stack.

The bigger competitive implication is that Microsoft’s scale may force smaller cloud and infrastructure players into worse economics just to stay relevant. If Azure growth holds near the high-30s while capex rises, the pressure shifts downstream to vendors with less pricing power: networking, power, and chip suppliers benefit near term, but anyone selling commoditized compute or adjacent cloud services risks margin compression as Microsoft leverages procurement scale. That also raises the bar for competitors’ AI monetization timelines; if they can’t show backlog translation into revenue within the next 2-4 quarters, valuation dispersion should widen.

The contrarian miss is that investors may be treating backlog as fully monetizable without discounting execution risk on deployment timing, customer churn, or model economics. The near-term catalyst is the next two earnings prints: if capex intensity rises again but Azure growth merely holds, the stock can still rerate on operating leverage; if growth decelerates while spend stays elevated, the multiple compresses fast. The setup is less about whether AI demand exists and more about whether Microsoft can keep converting that demand into cash flow faster than the market is already underwriting.

Key Decisions for Investors

• Add to MSFT on 4-8 week weakness toward prior support levels; use a staggered entry because the stock can remain range-bound until the next earnings confirmation. Risk/reward favors owning the name into the next print if Azure growth stays in the high-30s and capex does not accelerate materially beyond current expectations.
• Buy MSFT 6-12 month call spreads rather than outright calls to capture rerating while limiting downside if AI capex sentiment sours. Structure should target a move back toward consensus valuation upside with defined premium outlay.
• Pair trade: long MSFT / short a basket of smaller cloud-infrastructure or AI-enablement names with weaker cash generation and less backlog visibility. This expresses the thesis that scale and balance-sheet strength win as AI spend matures.
• Overweight select semiconductor and networking suppliers tied to Azure deployments only on pullbacks, not breakouts, because the trade is now more about capex digestion than pure demand acceleration. Expect upside to be more idiosyncratic and less linear over the next 1-2 quarters.
• Use any post-earnings gap-down in MSFT caused by capex fears as a buy-the-dip opportunity unless backlog conversion or cloud growth visibly slows for two consecutive quarters. If both deteriorate, exit quickly—the bear case is a multiple reset, not a gradual derating.